Author: Gemma Dunn, Head of Inbound Marketing at ramarketing With 2024 officially underway, the global life science marketing space finds itself, as always, facing challenges and opportunities. The need for innovation and to attract and convert buyers in a hugely competitive space whilst staying on top of industry advancements remains crucial. New marketing trends are always emerging across every sector and the pharmaceutical and contract outsourcing space is no different. Companies operating in life sciences are still feeling the aftermath of the COVID come down which has left a greater need ..read more

Life science industry organisation Medilink Midlands has announced the permanent appointment of Melanie Davidson as Chief Executive Officer, and Andrea Dawson as Chief Financial and Operating Officer. Having both fulfilled their roles in an interim capacity since March 2023, Melanie and Andrea are now permanently appointed to their new positions. Medilink Midlands is the life science industry association for the Midlands, helping life science companies to set up, develop and grow. Working alongside regional organisations including the East and West Midlands Academic Health Science Networks, th ..read more

Commercial research is showing clear signs of recovery since the pandemic according to the latest annual statistics reported by the NIHR Clinical Research Network (CRN). There were 1,757 commercial studies on the NIHR CRN Portfolio, up by almost 200 on pre-pandemic levels (2019/20).The number of new industry led studies in 2022/23 has also increased to 764, exceeding 671 studies in 2019/20 This has enabled 32,328 participants to be part of commercial studies sponsored by the life sciences industry which compares to 28,832 in 2019/20. The figures collected and published each ..read more

UpsLeading science and innovation campus, Discovery Park, in Sandwich, Kent has launched a new business support programme and competition, ‘Discovery Spark’. The programme will lay healthy foundations for future company success and equip early stage life science businesses with the skills needed when pitching to investors. The free and hybrid programme running over the course of eight weeks, aims to ignite potential from the best of Discovery Park’s facilities, people and networks. Delivered in four in-person sessions, plus mentoring, networking and group learning, the sessions will cover team ..read more

LightOx, based in Newcastle, has developed a UK-first solution for early-stage mouth cancers using light-activated chemotherapy. The treatment involves a gel being applied to the affected area and the drug activated with light. It is undergoing preclinical testing, is quick, simple and non-invasive with fewer side effects than surgery and significantly improves the overall patient experience. Through Analysis for Innovators (A4I), a grant funding programme run by Innovate UK, the UK’s innovation agency, LightOx was able to access expertise and an unparalleled range of state-of-the-art laser te ..read more

Medical Fair India takes place in New Delhi, from 27th to 29th April. The show has been chosen because of the importance of the Indian market for medical devices, ranking among the global top 20. It is now one of the world’s fastest growing marketplaces for healthcare technology. The company will be providing support for companies wishing to enter or expand into this exciting region. June sees the return of the Florida International Medical Expo (FIME), the leading trade show for those wanting to do business in the medical device and equipment sector in the Americas. The exhibition usually att ..read more

Bruntwood SciTech is set to invest a further £60m into Manchester Science Park (MSP) and support the creation of over 2,500 jobs, as it unveils plans for an additional 131,000 sq ft of world-class, highly specialist lab space to continue to build on the North West’s world-leading cluster of clinical, academic and commercial life sciences assets, companies and expertise. The plans, which represent the third phase of Bruntwood SciTech’s masterplan to grow the campus to 1m sq ft following the completion of its purpose-built Industry 4.0 hub Base in July 2022, will see the existing Greenheys site ..read more

This unique event focuses exclusively on the design, development and production of medical devices (of all classes) IVD’s, dental and healthcare. It serves the needs of the UK’s diversemedical device manufacturing industry, the third largest in Europe. It is the sister event to the similarly focused, highly regarded and respected Medical Technology Ireland, now in its sixth year. Medical Technology UK 2023 is a two-day exhibition showcasing 150 specialist companies from all tiers of the medical device manufacturing supply chain. In tandem with the unrivalled exhibition is the Learning Pro ..read more

This unique event focuses exclusively on the design, development and production of medical devices (of all classes) IVD’s, dental and healthcare. It serves the needs of the UK’s diversemedical device manufacturing industry, the third largest in Europe. It is the sister event to the similarly focused, highly regarded and respected Medical Technology Ireland, now in its sixth year. Medical Technology UK 2023 is a two-day exhibition showcasing 150 specialist companies from all tiers of the medical device manufacturing supply chain. In tandem with the unrivalled exhibition is the Learning Pro ..read more

A UK based manufacturer, Sterimedix Ltd, are showcasing how they have become a world leader in the development of ophthalmic and aesthetic cannulas, when they attend this year’s Arab Health as part of their continued expansion intointernational markets. The range of single-use cannulas has had global success due to Sterimedix’ ability to combine the latest technology with quality manufacturing standards, maintained across high volume production. In the last 10 years alone, Sterimedix have produced over 100 million devices. Established over thirty years ago on the premise that single-use instr ..read more